Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

Brunstein et al describe successful use of cord blood derived regulatory T cells in prevention of graft vs host disease (GvHD). This establishes a clinical response to target in deriving similar cells from pluripotent stem cells. Read more.

Related News

Press Releases

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

May 26, 2021
Research Insights

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

June 27, 2019
Research Insights

Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy

June 27, 2019
Press Releases

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

May 26, 2021
Research Insights

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

June 27, 2019
Research Insights

Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy

June 27, 2019